NCT01127854
Pilot Study to Evaluate the Contribution of Gene Variants to Idiopathic Urolithiasis
Enrolling by Invitation
Not specifiedAges 18+ObservationalMayo ClinicInvestigator-initiated
~2,900 participants
Updated 2026-01-23 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
To identify the frequency of known genetic variants associated with monogenic forms of nephrolithiasis within idiopathic stone forming populations and associate their presence with heightened risk.
Measured over December 2018
Conditions
Where it's being run
1 sites across 1 statesFlorida1
Study leadership
- William E Haley, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
History of calcium oxalate stones
18 years of age or older
Willing to provide a blood sample, and questionnaire
18 years of age or older
No personal history of urolithiasis
Willing to provide a blood sample and questionnaire
Exclusion
Secondary causes of urolithiasis including: Bowel disease, Renal tubular acidosis, hyperparathyroidism
What this trial measures
- To identify the frequency of known genetic variants associated with monogenic forms of nephrolithiasis within idiopathic stone forming populations and associate their presence with heightened risk.December 2018